UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Correlation of Blood Biomarkers and Biomarker Panels with Traumatic Findings on Computed Tomography after Traumatic Brain Injury

Journal of neurotrauma, 2019-07, Vol.36 (14), p.2178-2189

2019

Volltextzugriff (PDF)

Early measurement of interleukin-10 predicts the absence of CT scan lesions in mild traumatic brain injury

PloS one, 2018-02, Vol.13 (2), p.e0193278-e0193278

2018

Volltextzugriff (PDF)

Diagnostic performance of peroxiredoxin 1 to determine time-of-onset of acute cerebral infarction

Scientific reports, 2016-12, Vol.6 (1), p.38300-38300, Article 38300

2016

Volltextzugriff (PDF)

Combining H-FABP and GFAP increases the capacity to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury

PloS one, 2018-07, Vol.13 (7), p.e0200394-e0200394

2018

Volltextzugriff (PDF)

H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury

PloS one, 2017-04, Vol.12 (4), p.e0175572-e0175572

2017

Volltextzugriff (PDF)

Early Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein in Predicting the Outcome of Mild Traumatic Brain Injury

Journal of neurotrauma, 2019-05, Vol.36 (10), p.1551-1560

2019

Volltextzugriff (PDF)

Interleukin 10 and Heart Fatty Acid-Binding Protein as Early Outcome Predictors in Patients With Traumatic Brain Injury

Frontiers in neurology, 2020-06, Vol.11, p.376-376

2020

Volltextzugriff (PDF)

E-selectin and vascular cell adhesion molecule-1 as biomarkers of 3-month outcome in cerebrovascular diseases

Journal of inflammation (London, England), 2015-11, Vol.12 (61), p.61-61, Article 61

2015

Volltextzugriff (PDF)

Admission Levels of Interleukin 10 and Amyloid β 1–40 Improve the Outcome Prediction Performance of the Helsinki Computed Tomography Score in Traumatic Brain Injury

Frontiers in neurology, 2020-10, Vol.11, p.549527-549527

2020

Volltextzugriff (PDF)

Potential of heart fatty-acid binding protein, neurofilament light, interleukin-10 and S100 calcium-binding protein B in the acute diagnostics and severity assessment of traumatic brain injury

Emergency medicine journal : EMJ, 2022-03, Vol.39 (3), p.206-212

2022

Volltextzugriff (PDF)

Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing

The Journal of molecular diagnostics : JMD, 2015-07, Vol.17 (4), p.456-461

2015

Volltextzugriff (PDF)

Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events

Genetics in medicine, 2015-03, Vol.17 (3), p.177-187

2015

Volltextzugriff (PDF)

Variability in gene-based knowledge impacts variant classification: an analysis of FBN1 missense variants in ClinVar

European journal of human genetics : EJHG, 2019-10, Vol.27 (10), p.1550-1560

2019

Volltextzugriff (PDF)

Decreased frequency of FBN1 missense variants in Ghent criteria-positive Marfan syndrome and characterization of novel FBN1 variants

Journal of human genetics, 2015-05, Vol.60 (5), p.241-252

2015

Volltextzugriff (PDF)

Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade

The Journal of molecular diagnostics : JMD, 2016-05, Vol.18 (3), p.438-445

2016

Volltextzugriff (PDF)

UGT1A1 Genetic Analysis as a Diagnostic Aid for Individuals with Unconjugated Hyperbilirubinemia

The Journal of pediatrics, 2013-06, Vol.162 (6), p.1146-1152.e2

2013

Volltextzugriff (PDF)

Shedding of chlamydiae in relation to titers of serum chlamydiae-specific antibodies and serum concentrations of two acute-phase proteins in cats without conjunctivitis

American journal of veterinary research, 2011-06, Vol.72 (6), p.806-812

2011

Volltextzugriff (PDF)

Preemptive Pharmacogenomic Testing for Precision Medicine

The Journal of molecular diagnostics : JMD, 2016-05, Vol.18 (3), p.438-445

2016

Volltextzugriff (PDF)

Genetic and biochemical analyses in dyslipidemic patients undergoing LDL apheresis

Journal of clinical apheresis, 2014-10, Vol.29 (5), p.256-265

2014

Volltextzugriff (PDF)

LDLR promoter variant and exon 14 mutation on the same chromosome are associated with an unusually severe FH phenotype and treatment resistance

European journal of human genetics : EJHG, 2009-01, Vol.17 (1), p.85-90

2009

Volltextzugriff (PDF)

Genetic and biochemical analyses in dyslipidemic patients undergoing LDL apheresis: Analysis of Dyslipidemic LDL Apheresis Patients

Journal of clinical apheresis, 2014-10, Vol.29 (5), p.256-265

2014

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Correlation of Blood Biomarkers and Biomarker Panels with Traumatic Findings on Computed Tomography after Traumatic Brain Injury

Early measurement of interleukin-10 predicts the absence of CT scan lesions in mild traumatic brain injury

Diagnostic performance of peroxiredoxin 1 to determine time-of-onset of acute cerebral infarction

Combining H-FABP and GFAP increases the capacity to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury

H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury

Early Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein in Predicting the Outcome of Mild Traumatic Brain Injury

Interleukin 10 and Heart Fatty Acid-Binding Protein as Early Outcome Predictors in Patients With Traumatic Brain Injury

E-selectin and vascular cell adhesion molecule-1 as biomarkers of 3-month outcome in cerebrovascular diseases

Admission Levels of Interleukin 10 and Amyloid β 1–40 Improve the Outcome Prediction Performance of the Helsinki Computed Tomography Score in Traumatic Brain Injury

Potential of heart fatty-acid binding protein, neurofilament light, interleukin-10 and S100 calcium-binding protein B in the acute diagnostics and severity assessment of traumatic brain injury

Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing

Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events

Variability in gene-based knowledge impacts variant classification: an analysis of FBN1 missense variants in ClinVar

Decreased frequency of FBN1 missense variants in Ghent criteria-positive Marfan syndrome and characterization of novel FBN1 variants

Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade

UGT1A1 Genetic Analysis as a Diagnostic Aid for Individuals with Unconjugated Hyperbilirubinemia

Shedding of chlamydiae in relation to titers of serum chlamydiae-specific antibodies and serum concentrations of two acute-phase proteins in cats without conjunctivitis

Preemptive Pharmacogenomic Testing for Precision Medicine

Genetic and biochemical analyses in dyslipidemic patients undergoing LDL apheresis

LDLR promoter variant and exon 14 mutation on the same chromosome are associated with an unusually severe FH phenotype and treatment resistance

Genetic and biochemical analyses in dyslipidemic patients undergoing LDL apheresis: Analysis of Dyslipidemic LDL Apheresis Patients

Suchergebnisse filtern